Trial Profile
Phase III trial of lurasidone in patients with schizophrenia aged 10-17 years.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 22 Feb 2012
Price :
$35
*
At a glance
- Drugs Lurasidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Sumitomo Pharma
- 22 Feb 2012 New trial record